In fact, the miR-365-3p/KRT16 signaling also pertains the ability to regulate cancer stemness and drug resistance via interaction with the β5-integrin/c-Met pathway in promoting tumorigenesis of OSCC. This evidence concerns the gene KRT16 and cancer.